BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 24223934)

  • 1. An anthelmintic drug, pyrvinium pamoate, thwarts fibrosis and ameliorates myocardial contractile dysfunction in a mouse model of myocardial infarction.
    Murakoshi M; Saiki K; Urayama K; Sato TN
    PLoS One; 2013; 8(11):e79374. PubMed ID: 24223934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effect of pyrvinium pamoate on uveal melanoma cells involves blocking of Wnt/β-catenin pathway.
    Zheng L; Liu Y; Pan J
    Acta Biochim Biophys Sin (Shanghai); 2017 Oct; 49(10):890-898. PubMed ID: 28981601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyrvinium, a potent small molecule Wnt inhibitor, promotes wound repair and post-MI cardiac remodeling.
    Saraswati S; Alfaro MP; Thorne CA; Atkinson J; Lee E; Young PP
    PLoS One; 2010 Nov; 5(11):e15521. PubMed ID: 21170416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The FDA-Approved Anthelmintic Pyrvinium Pamoate Inhibits Pancreatic Cancer Cells in Nutrient-Depleted Conditions by Targeting the Mitochondria.
    Schultz CW; McCarthy GA; Nerwal T; Nevler A; DuHadaway JB; McCoy MD; Jiang W; Brown SZ; Goetz A; Jain A; Calvert VS; Vishwakarma V; Wang D; Preet R; Cassel J; Summer R; Shaghaghi H; Pommier Y; Baechler SA; Pishvaian MJ; Golan T; Yeo CJ; Petricoin EF; Prendergast GC; Salvino J; Singh PK; Dixon DA; Brody JR
    Mol Cancer Ther; 2021 Nov; 20(11):2166-2176. PubMed ID: 34413127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of pyrvinium pamoate against Cryptosporidium parvum infection in vitro and in a neonatal mouse model.
    Downey AS; Chong CR; Graczyk TK; Sullivan DJ
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3106-12. PubMed ID: 18591280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible repurposing of pyrvinium pamoate for the treatment of mesothelioma: A pre-clinical assessment.
    Barbarino M; Cesari D; Intruglio R; Indovina P; Namagerdi A; Bertolino FM; Bottaro M; Rahmani D; Bellan C; Giordano A
    J Cell Physiol; 2018 Sep; 233(9):7391-7401. PubMed ID: 29659015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blocking STAT3 by pyrvinium pamoate causes metabolic lethality in KRAS-mutant lung cancer.
    Feng J; Jiang W; Liu Y; Huang W; Hu K; Li K; Chen J; Ma C; Sun Z; Pang X
    Biochem Pharmacol; 2020 Jul; 177():113960. PubMed ID: 32298693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyrvinium pamoate inhibits proliferation and invasion of human endometriotic stromal cells.
    Karamian A; Nazarian H; Ziai SA; Zarnani AH; Salehpour S; Paktinat S; Novin MG
    Hum Exp Toxicol; 2020 May; 39(5):662-672. PubMed ID: 31880170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting of Wnt/β-Catenin by Anthelmintic Drug Pyrvinium Enhances Sensitivity of Ovarian Cancer Cells to Chemotherapy.
    Zhang C; Zhang Z; Zhang S; Wang W; Hu P
    Med Sci Monit; 2017 Jan; 23():266-275. PubMed ID: 28090074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anthelmintic studies on pyrvinium pamoate (Povan) and other drugs in rodents, dogs, and monkeys.
    THOMPSON PE; WORLEY DE; MEISENHELDER JE
    Am J Trop Med Hyg; 1962 Jan; 11():89-95. PubMed ID: 13920921
    [No Abstract]   [Full Text] [Related]  

  • 11. The novel role of pyrvinium in cancer therapy.
    Momtazi-Borojeni AA; Abdollahi E; Ghasemi F; Caraglia M; Sahebkar A
    J Cell Physiol; 2018 Apr; 233(4):2871-2881. PubMed ID: 28500633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of enterobiasis with pyrantel pamoate. Comparative study with pyrvinium pamoate].
    Baranski MC; Carneiro Filho M; Gusso JF; Tarran AF
    Rev Inst Med Trop Sao Paulo; 1971; 13(6):422-7. PubMed ID: 5124651
    [No Abstract]   [Full Text] [Related]  

  • 13. Genetic activity in Saccharomyces cerevisiae and thin-layer chromatographic comparisons of medical grades of pyrvinium pamoate and monopyrvinium salts.
    Mehta RD; Hennig UG; von Borstel RC; Chatten LG
    Mutat Res; 1982; 102(1):59-69. PubMed ID: 6750373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antihelmintic drug pyrvinium pamoate targets aggressive breast cancer.
    Xu W; Lacerda L; Debeb BG; Atkinson RL; Solley TN; Li L; Orton D; McMurray JS; Hang BI; Lee E; Klopp AH; Ueno NT; Reuben JM; Krishnamurthy S; Woodward WA
    PLoS One; 2013; 8(8):e71508. PubMed ID: 24013655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyrvinium targets autophagy addiction to promote cancer cell death.
    Deng L; Lei Y; Liu R; Li J; Yuan K; Li Y; Chen Y; Liu Y; Lu Y; Edwards CK; Huang C; Wei Y
    Cell Death Dis; 2013 May; 4(5):e614. PubMed ID: 23640456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the genetic activity of pyrvinium pamoate with that of several other anthelmintic drugs in Saccharomyces cerevisiae.
    Hennig UG; Galindo-Prince OC; Cortinas de Nava C; Savage EA; von Borstel RC
    Mutat Res; 1987 Feb; 187(2):79-89. PubMed ID: 3543669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroblast Primary Cilia Are Required for Cardiac Fibrosis.
    Villalobos E; Criollo A; Schiattarella GG; Altamirano F; French KM; May HI; Jiang N; Nguyen NUN; Romero D; Roa JC; García L; Diaz-Araya G; Morselli E; Ferdous A; Conway SJ; Sadek HA; Gillette TG; Lavandero S; Hill JA
    Circulation; 2019 May; 139(20):2342-2357. PubMed ID: 30818997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyrvinium pamoate lacks in vivo genotoxicity in the colon.
    Goldberg MT
    Toxicol Appl Pharmacol; 1984 Jun; 74(2):293-5. PubMed ID: 6740678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An anticancer agent, pyrvinium pamoate inhibits the NADH-fumarate reductase system--a unique mitochondrial energy metabolism in tumour microenvironments.
    Tomitsuka E; Kita K; Esumi H
    J Biochem; 2012 Aug; 152(2):171-83. PubMed ID: 22528668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of oxiuriasis and ascaridiasis with the medicamentous combination of pyrvinium pamoate and diethylenediamine kainate].
    Fajardo Mateos C; Gadea Garrido B
    Acta Pediatr Esp; 1965 Nov; 23(275):1107-22. PubMed ID: 5850913
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.